Amarin Corp Plcuk (AMRN) Enterprise Value Growth (3y) (2013 - 2026)

Amarin Corp Plcuk (AMRN) Enterprise Value Growth (3y) (2013 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Amarin Corp Plcuk 5.17 Bn 5.00 Bn 17.77 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 16.53%
Dec 31, 2025 -48.60%
Sep 30, 2025 -34.71%
Jun 30, 2025 1.57%
Mar 31, 2025 23.46%
Dec 31, 2024 27.44%
Sep 30, 2024 13.92%
Jun 30, 2024 -18.16%
Mar 31, 2024 43.11%
Dec 31, 2023 37.56%
Sep 30, 2023 55.24%
Jun 30, 2023 38.17%
Mar 31, 2023 -11.92%
Dec 31, 2022 -186.85%
Sep 30, 2022 53.63%
Jun 30, 2022 -12.20%
Mar 31, 2022 -522.67%
Dec 31, 2021 -22.14%
Sep 30, 2021 -80.20%
Jun 30, 2021 -22.03%